Cargando…
Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation
Recently, several cases of fatal lymphocytic choriomeningitis virus (LCMV) infection occurred in transplant recipients being treated with the immunosuppressive calcineurin inhibitor FK506. These findings were surprising because LCMV is a noncytolytic virus. To understand how a noncytolytic virus can...
Autores principales: | Araki, Koichi, Gangappa, Shivaprakash, Dillehay, Dirck L., Rouse, Barry T., Larsen, Christian P., Ahmed, Rafi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964579/ https://www.ncbi.nlm.nih.gov/pubmed/20921283 http://dx.doi.org/10.1084/jem.20100124 |
Ejemplares similares
-
Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
por: Sieber, Matthias, et al.
Publicado: (2009) -
Treatment With Calcineurin Inhibitor FK506 Attenuates Noise-Induced Hearing Loss
por: He, Zu-Hong, et al.
Publicado: (2021) -
Physosmotic Induction of Chondrogenic Maturation Is TGF-β Dependent and Enhanced by Calcineurin Inhibitor FK506
por: Jahr, Holger, et al.
Publicado: (2022) -
FK506 reduces calpain-regulated calcineurin activity in both the cytoplasm and the nucleus
por: Lee, Sun Hee, et al.
Publicado: (2014) -
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020)